MedTrace Logo

Computational Decision Support in Epilepsy Using Retrospective EEG

NCT05384782 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 825

Last updated 2022-05-20

No results posted yet for this study

Summary

The primary aim is to validate a set of computational biomarkers as potential decision support in epilepsy on a large cohort of study participants that were diagnosed with epilepsy and controls that ended up with another diagnosis (such as syncope or non-epileptic seizures). The goal is to examine if the methodology works robustly on this large cohort, and can theoretically contribute to the reduction of misdiagnosis rates.

The secondary aim is to examine whether the computational biomarkers could contribute to reducing the waiting time and the number of clinical appointments needed before a final diagnosis is made.

Conditions

Sponsors & Collaborators

  • Neuronostics Ltd

    collaborator INDUSTRY

  • Cornwall Partnership NHS Foundation Trust

    lead NETWORK

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-01
Primary Completion
2021-12-31
Completion
2022-03-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05384782 on ClinicalTrials.gov